News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on HitIQ.
RELATED STOCKHEAD STORIES
News
ASX Small Caps Lunch Wrap: Anyone else feeling a little bit topsy turvy today?
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Local market on its knees after Fed’s big night of being tight; Norfolk Minerals up 137%
News
ASX Small Caps Lunch Wrap: Who wants to sign a petition to get Powell to stop saying stuff for a while?
Health & Biotech
ASX Health Stocks: HitIQ soars 40pc after signing footy deal; Rhythm Bio expands to NZ
News
Top 10 at 10: The tenacious ASX tech, copper and critical mineral stocks taking off on a tumultuous Thursday
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
ASX Biotech Stocks: HitIQ nabs landmark deal with Premier League for its concussion management tech
Health & Biotech
ASX Biotech Stocks: Surgeons can now be reimbursed for using Orthocell’s nerve repair device
Experts
CRITERION: Gains without pains? Maybe tackle these sporting injury stocks instead
Health & Biotech
ASX Health Stocks: HITIQ signs renewed deal with English cricket to manage concussion injuries
News
Market Highlights: Fed comments to cripple markets and 5 ASX small caps to watch
Health & Biotech
ASX Health Stocks: Patrys says brain cancer drug is effective; HitIQ awarded Aussie patent
Health & Biotech
Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit
Health & Biotech
ASX Health Stocks: HitIQ and Volpara prove world class technology after signing major US deals
Health & Biotech
Cast your eyes over these 15 weird and wonderful biotech stocks we found on the ASX
Health & Biotech
